1. Home
  2. MGRX

as 12-18-2024 11:39am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Technology

Computer Software: Prepackaged Software

Nasdaq

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Founded: 2021 Country:
United States
United States
Employees: N/A City: DALLAS
Market Cap: 6.3M IPO Year: 2023
Target Price: N/A AVG Volume (30 days): 59.1K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -5.65 EPS Growth: N/A
52 Week Low/High: $2.10 - $16.80 Next Earning Date: 11-14-2024
Revenue: $755,000 Revenue Growth: 52.20%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

MGRX Daily Stock ML Predictions

Share on Social Networks: